Abstract:Background: The Alaska Tribal Health System is working on increasing colorectal cancer (CRC) screening rates among Alaska Native people, who have the highest CRC rates in the world. Most remote Alaska Native communities are not connected to the road system, which severely limits access to screening colonoscopy. As part of a clinical trial, Alaska Native patients were offered either colonoscopy or the at-home multi-target stool DNA test (mt-sDNA; Cologuard®). Patients had never been offered mt-sDNA before and it was unknown what they would think about the new test option. Both tests were provided at no cost to patients. Methods: From April 2022 to July 2023, 194 patients who chose mt-sDNA for screening received a follow-up phone survey asking whether they were aware that they could have had colonoscopy instead, their reasons for choosing mt-sDNA, and the factors influencing their choice of mt-sDNA over colonoscopy. Patients answered the survey before receiving results of their mt-sDNA test in order to capture initial screening test preferences. Results: A total of 115 (59%) Alaska Native patients participated in the survey; 56% men and 44% women. About 70% were ages 45 to 60 years while the remaining 30% were 61 to 75 years old. The majority (80%) were aware that they had the option to undergo colonoscopy for CRC screening instead of mt-sDNA. Key themes for mt-sDNA preference included not having to travel, less time commitment, and greater convenience. Many patients expressed financial concerns arising from the costs of air travel and accommodation required to access screening colonoscopy even though the procedure itself was covered. Additionally, patients highlighted existing obligations such as childcare and work responsibilities which made the use of mt-sDNA at home more appealing. Many respondents also shared negative perceptions of colonoscopy procedure including fear, embarrassment, and discomfort as reasons why they preferred mt-sDNA instead. Conclusions: These findings demonstrate the multifaceted factors influencing the preference for at-home mt-sDNA CRC screening among Alaska Native individuals. Challenges such as limited access to medical facilities, financial burdens, and personal commitments have significant bearing on the screening decision-making process. Moreover, the emotional aspect of fear and discomfort associated with colonoscopy plays a role in shaping these preferences. CRC screening programs need to be aware of patient needs and preferences when deciding which screening methods to offer to increase screening rates and result in improved colorectal health outcomes. Citation Format: Diana Redwood. Preference for multi-target stool DNA for colorectal cancer screening among Alaska Native people in rural/remote communities [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 4787.

Health Care Provider Characteristics Associated With Colorectal Cancer Screening Preferences and Use

Occupational asthma due to azobisformamide

Repair and reoxygenation following irradiation of an in vitro tumor model.

Alternative timeframes for hemodialysis.

Construction of a family of universal expression plasmid vectors.

S538 Assessing Patient Preferences for Blood-Based Colorectal Cancer (CRC) Screening Tests: Insights from a Conjoint Analysis with Over 1,000 People in the US

"I was screaming hallelujah": Patient and provider perceptions of blood-based testing for colorectal cancer screening

Trends in colorectal cancer screening from NHIS survey: Analysis of modalities impact on overall screening.

Colorectal Cancer Screening in Adults 45-49: Provider Availability, CT Colonography Access, and Screening Rates

Provider communication contributes to colorectal cancer screening intention through improving screening outcome expectancies and perceived behavioral control

DEVELOPMENT , TESTING AND APPLICATION OF LAMINAR MULTIELECTRODES AND BIOCOMPATIBLE COATINGS FOR INTRACORTICAL APPLICATIONS

Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening

Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial

The impact of multi-target stool DNA testing in clinical practice in the United States: A real-world evidence retrospective study

Trends in Colorectal Cancer Screening from the National Health Interview Survey: Analysis of the Impact of Different Modalities on Overall Screening Rates

Acceptance of flexible sigmoidoscopy screening for colorectal cancer

Advancing Colorectal Cancer Detection With Blood-Based Tests: Qualitative Study and Discrete Choice Experiment to Elicit Population Preferences

Examining colorectal cancer screening uptake and health provider recommendations among underserved middle aged and older African Americans

Changes in the Choice of Colorectal Cancer Screening Tests in Primary Care Settings from 7,845 Prospectively Collected Surveys

Abstract 4787: Preference for multi-target stool DNA for colorectal cancer screening among Alaska Native people in rural/remote communities

Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk